New app aims to tackle diabetes stress in School-Age children

NCT ID NCT05268250

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study tests a mobile health program called R2D2 designed to reduce diabetes distress in children aged 8-12 with type 1 diabetes and their parents. The program uses cognitive behavioral therapy, mindfulness, and behavioral strategies to help families cope. Researchers will measure changes in blood sugar control and emotional well-being in 180 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
R2D2 mHealth intervention (behavioral therapy using cognitive behavioral therapy, mindfulness, and behavioral activation strategies)
What this could lead to
If it works, this could provide a scalable, low-cost way to help families manage the emotional burden of type 1 diabetes and improve children's blood sugar levels.
What could go wrong
This is an early feasibility and efficacy trial with only 180 participants, so results may not apply to everyone. The intervention is behavioral, so benefits may vary and long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Mercy Kansas City

    Kansas City, Missouri, 64108, United States

  • Nemours Children's Health

    Jacksonville, Florida, 32207, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.